Krishbaj India Pharmaceuticals Private Limited
About Krishbaj India Pharmaceuticals Private Limited
Data last updated:
Krishbaj India Pharmaceuticals Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 21 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24230OR2015PTC019314. Its GSTIN is 21AAFCK9161J1ZG (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Anusaya Rout and Sushila Kumar Rout.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at At – Haridaspur Po – Naharakanta Ps – Mancheswar, Bhubaneswar, Odisha, India – 752101.
As per the financials filed for FY 2024, the company reported a revenue of ₹71.86 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹11,033 (net margin 0.2%) and EBITDA of ₹88,326 (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Krishbaj India Pharmaceuticals Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressAt – Haridaspur Po – Naharakanta Ps – Mancheswar, Bhubaneswar, Odisha, India – 752101
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Krishbaj India Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Krishbaj India Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Krishbaj India Pharmaceuticals Private Limited, buy the company report.
Financials of Krishbaj India Pharmaceuticals Private Limited
FY 2024 filings availableKrishbaj India Pharmaceuticals Private Limited reported revenue of ₹71.86 Lakh (down 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 24% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹88,326 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11,033 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Krishbaj India Pharmaceuticals Private Limited, buy the company report.
Board of directors of Krishbaj India Pharmaceuticals Private Limited
Krishbaj India Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anusaya Rout | Director | 21 Aug 2015 | 11 Years 2 Months | Current |
| Sushila Kumar Rout | Director | 28 Nov 2019 | 6 Years 10 Months | Current |
Peer comparison
Krishbaj India Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Voluenta Pharmaceuticals Private Limited | ₹72.03 Lakh (FY 2025) | -22.0% | New Delhi, Delhi, India | |||
| Krishbaj India Pharmaceuticals Private Limitedthis company | ₹71.86 Lakh (FY 2024) | ₹11,033 | 0.2% | -24.0% | Bhubaneswar, Odisha, India | |
| Vizag Pharmaceuticals Private Limited | ₹70.81 Lakh (FY 2016) | -52.0% | Hyderabad, Telangana, India | |||
| Ecstatic Pharmaceuticals Private Limited | ₹70.76 Lakh (FY 2023) | 13.0% | Thane, Maharashtra, India |
To see the full peer comparison of Krishbaj India Pharmaceuticals Private Limited, buy the company report.
Auditor
Krishbaj India Pharmaceuticals Private Limited is audited by AMITAV MISHRA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMITAV MISHRA & CO. | FY 2017 | 209345 |
Shareholding
The shareholding of Krishbaj India Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Krishbaj India Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Krishbaj India Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Krishbaj India Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Krishbaj India Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAFCK9161J1ZG | Odisha | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Krishbaj India Pharmaceuticals Private Limited, buy the company report.
Recent activity
Krishbaj India Pharmaceuticals Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Tapasi Manjari Samal ceased to be Director on 17 Dec 2019.
Frequently asked questions
Krishbaj India Pharmaceuticals is an active private limited company based in Bhubaneswar, Odisha, India. The company works in other wholesale, within the trading industry. It was incorporated on 21 August 2015 (11+ years old) and is registered under CIN U24230OR2015PTC019314.
Krishbaj India Pharmaceuticals has 2 current directors:
- Anusaya Rout - Director
- Sushila Kumar Rout - Director
The latest financial statements of Krishbaj India Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Krishbaj India Pharmaceuticals is 21AAFCK9161J1ZG, registered in Odisha.
The CIN (Corporate Identification Number) of Krishbaj India Pharmaceuticals is U24230OR2015PTC019314. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Krishbaj India Pharmaceuticals was incorporated on 21 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Krishbaj India Pharmaceuticals by revenue are Voluenta Pharmaceuticals Private Limited, Vizag Pharmaceuticals Private Limited, Ecstatic Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Tapasi Manjari Samal ceased to be Director on 17 Dec 2019. Sushila Kumar Rout was appointed as Director on 28 Nov 2019. Anusaya Rout was appointed as Director on 21 Aug 2015. Krishbaj India Pharmaceuticals has 4 board changes on record in total.
The registered office of Krishbaj India Pharmaceuticals is at At – Haridaspur Po – Naharakanta Ps – Mancheswar, Bhubaneswar, Odisha, India – 752101.
Krishbaj India Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Krishbaj India Pharmaceuticals is compliant as of 07 August 2026. The company is actively filing with the Registrar of Companies.